October 15, 2025

EBSdart Tool Showed Strong Reliability in EBS

EBSdart introduces a standardized framework for epidermolysis bullosa simplex assessment.

Conexiant

October 14, 2025

Shingles Vaccine Effective in Immunocompromised Adults

Study of 3.5 million Medicare beneficiaries finds similar protection regardless of immune status.

Conexiant

October 14, 2025

Shingles Vaccine Effective in Immunocompromised Adults

Study of 3.5 million Medicare beneficiaries finds similar protection regardless of immune status.

Conexiant

October 06, 2025

More Tattoos, Lower Risk of Melanoma? New Study Investigates

People with more than one tattoo session may have a decreased risk of developing melanoma—with one key caveat, according to a study evaluating over 7,000 individuals.

The ASCO Post

October 06, 2025

Dupilumab Shows High Treatment Persistence in AD

Biologics target type 2 inflammation in atopic dermatitis, improving skin barrier and symptoms.

Conexiant

April 29, 2024

First Death From Alaskapox Reported

Alaska health officials warned of the risk of Alaskapox in the wake of the first death from the disease in January 2024.

Conexiant

June 12, 2024

FAc Implant Shows Sustained Improvement in Uveitis

Long-term study highlights effectiveness of fluocinolone acetonide implant in managing non-infectious posterior uveitis, maintaining stable intraocular pressure.

Conexiant

February 01, 2023

How to Upgrade Your Informed Consent Efforts

PentaVision is an independent company dedicated to eye care professionals. More about our magazines, newsletters, conferences, education and other services at pentavisionmedia.com.

Ophthalmology Management

April 29, 2024

Record Heat Waves Propel Surge in Heat-Related Illness

2023 brought record-breaking heat waves in the United States, significantly impacting vulnerable groups. Analysis by the CDC revealed a substantial number of heat-related illness (HRI) emergency department visits, resulting in multiple public health alerts.

Conexiant